
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.330 | 0.330 | 0.000 |
Shares | 99.670 | 99.670 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.994 | 19.700 |
Price to Book | 2.949 | 3.867 |
Price to Sales | 2.564 | 2.233 |
Price to Cash Flow | 9.289 | 15.117 |
Dividend Yield | 3.027 | 1.463 |
5 Years Earnings Growth | 5.583 | 10.702 |
Number of long holdings: 26
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 7.65 | 96.18 | +0.17% | |
Roche Holding Participation | CH0012032048 | 7.35 | 261.60 | -0.19% | |
AstraZeneca | GB0009895292 | 7.02 | 10,224.0 | +0.79% | |
J&J | US4781601046 | 6.92 | 152.41 | +0.26% | |
Merck&Co | US58933Y1055 | 4.95 | 79.10 | +0.34% | |
Bayer | DE000BAY0017 | 4.45 | 26.98 | +2.66% | |
Gilead | US3755581036 | 4.00 | 110.67 | +2.83% | |
Chugai Pharmaceutical | JP3519400000 | 3.95 | 7,533.0 | +0.24% | |
GSK plc | GB00BN7SWP63 | 3.89 | 1,405.50 | +0.75% | |
Takeda Pharmaceutical | JP3463000004 | 3.70 | 4,407.0 | +0.94% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson Co Global Top 25 Brands Fu | 669.73M | -6.97 | 4.96 | 9.08 | ||
Seligson & Co Global Top 25 Brands | 669.73M | -6.96 | 4.96 | 9.04 | ||
Seligson North American B | 549.78M | -5.31 | 13.60 | 12.34 | ||
Seligson & Co North American A | 549.78M | -6.02 | 13.33 | 12.27 | ||
FI4000283031 | 471.66M | -9.04 | 14.50 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review